Brokerages Set Addus HomeCare Corporation (NASDAQ:ADUS) PT at $138.89

Addus HomeCare Corporation (NASDAQ:ADUSGet Free Report) has been assigned an average rating of “Buy” from the ten analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, seven have issued a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $138.8889.

Several research analysts recently issued reports on the stock. Stephens reissued an “overweight” rating and set a $140.00 price target on shares of Addus HomeCare in a report on Wednesday, September 3rd. Barclays increased their target price on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a research note on Tuesday, August 19th. Royal Bank Of Canada lifted their price target on Addus HomeCare from $133.00 to $134.00 and gave the company an “outperform” rating in a research note on Friday, August 22nd. JMP Securities reiterated a “market outperform” rating and issued a $150.00 price objective on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, Wall Street Zen raised Addus HomeCare from a “hold” rating to a “buy” rating in a report on Sunday, June 29th.

Check Out Our Latest Report on ADUS

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $110.27 on Monday. The firm’s fifty day moving average price is $112.00 and its 200 day moving average price is $107.02. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of 24.34, a price-to-earnings-growth ratio of 1.72 and a beta of 0.85.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. During the same quarter in the prior year, the firm earned $1.35 EPS. Addus HomeCare’s quarterly revenue was up 21.8% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity

In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the sale, the director owned 5,067 shares in the company, valued at $582,350.31. This trade represents a 23.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $116.82, for a total transaction of $904,069.98. Following the transaction, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. The trade was a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock worth $3,958,375 in the last 90 days. 4.50% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently bought and sold shares of ADUS. Premier Fund Managers Ltd acquired a new stake in Addus HomeCare in the first quarter valued at $726,000. Deutsche Bank AG boosted its position in shares of Addus HomeCare by 50.0% in the 4th quarter. Deutsche Bank AG now owns 16,354 shares of the company’s stock worth $2,050,000 after buying an additional 5,448 shares in the last quarter. Bank of America Corp DE grew its stake in Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock valued at $21,945,000 after acquiring an additional 128,211 shares during the last quarter. HighTower Advisors LLC increased its holdings in Addus HomeCare by 62.4% during the 1st quarter. HighTower Advisors LLC now owns 4,671 shares of the company’s stock valued at $462,000 after acquiring an additional 1,795 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its holdings in Addus HomeCare by 77.6% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 8,836 shares of the company’s stock valued at $1,108,000 after acquiring an additional 3,862 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Articles

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.